Belite Bio (BLTE)
(Delayed Data from NSDQ)
$66.31 USD
-3.48 (-4.99%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $66.70 +0.39 (0.59%) 7:38 PM ET
4-Sell of 5 4
C Value C Growth F Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Belite Bio, Inc. Sponsored ADR's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
BLTE 66.31 -3.48(-4.99%)
Will BLTE be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BLTE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BLTE
New Strong Sell Stocks for August 4th
New Strong Sell Stocks for July 22nd
BLTE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for BLTE
Belite Bio to Host Webcast on August 11, 2025, to Discuss Second Quarter 2025 Financial Results ...
Belite Bio Inc (BLTE) Announces Upcoming Webcast for Q2 2025 Financial Results | BLTE stock news
Belite Bio to Participate in the BTIG Virtual Biotechnology Conference | BLTE Stock News
Belite Bio Inc (BLTE) to Participate in BTIG Virtual Biotechnology Conference | BLTE stock news
Bullish Two Hundred Day Moving Average Cross - BLTE